Rho small G protein and cytoskeletal control

Area of Science:

• Cell Biology
• Molecular Biology
• Biochemistry

Background:

• The Rho family, part of the Ras-related small GTP-binding protein superfamily, controls essential cellular processes involving the actomyosin system.
• Key regulators include GDP/GTP exchange proteins (GEPs) like Smg GDS, Dbl, Rho GDI, and GTPase activating proteins (GAPs) such as Rho GAP and p190 associated with Ras GAP.
• Rho activity is modulated by protein kinase C, linked via phospholipase C to membrane receptors, including tyrosine kinase-type and heterotrimeric G protein-linked receptors.

Purpose of the Study:

• To elucidate the regulatory mechanisms of Rho GTP-binding proteins.
• To understand the distinct signaling pathways of Ras and Rho proteins originating from membrane receptors.
• To explore the role of Rho signaling in carcinogenesis, specifically in cellular invasiveness and metastasis.

Main Methods:

• Literature review and synthesis of existing research on Rho family proteins.
• Analysis of signaling pathways involving Rho, Ras, and their regulators.
• Investigation of the link between Rho signaling and cancer progression.

Main Results:

• Rho proteins regulate diverse cell functions: morphology, motility, aggregation, cytokinesis, muscle contraction, and budding.
• Identified key regulatory proteins: GEPs (Smg GDS, Dbl, Rho GDI) and GAPs (Rho GAP, p190).
• Rho signaling is interconnected with other pathways (PKC, PLC, tyrosine kinases, heterotrimeric G proteins) and distinct from Ras signaling in signal transduction to genes and cytoskeleton.

Conclusions:

• Rho GTP-binding proteins are critical regulators of cell behavior and cytoskeletal organization.
• Aberrant Rho signaling contributes significantly to the invasiveness and metastasis of carcinoma cells.
• Understanding Rho pathways offers insights into cancer progression and potential therapeutic targets.